Menu

1 / 33

Rocket Lab: Buy The Dip, It's Not Rocket Science

All Articles on Seeking Alpha·2 days ago
#KBKtTJuH
#seekingalpha#neutron#rklb#million#rocket
Reading 0:00
15s threshold

James Foord Investing Group Leader

Summary

Rocket Lab Corporation is a Strong Buy with a $100 target; the Neutron delay is known, while the underlying business is improving.

RKLB's backlog reached $3.57 billion, up 52% sequentially, with Neutron demand and pricing strengthening despite the launch delay into 2027.

Q3 revenue rose 73% to $267.8 million, operating cash flow turned positive, and management expects EBITDA profitability within six months of a successful Neutron flight.

At 44x estimated 2026 sales, RKLB remains expensive; further Neutron delays, negative free cash flow and Iridium approval present risks. Leave room to add on dips.

This idea was discussed in more depth with members of my private investing community, The Pragmatic Investor. Learn More »

Black Friday Sale 2026: Get 20% Off

Infinite Creations/iStock via Getty Images

Thesis Summary

Rocket Lab Corporation (RKLB) has had a rough year.…

Continue reading — create a free account

Join HashtagPLUS to read full articles, follow hashtags, vote, and join the conversation.